Oct 6 2012
Stereotaxis, today announced that for the second consecutive quarter it has secured orders from hospitals looking to advance robotic research and support procedure growth through installation of a second Niobe® ES system.
Two of the total Niobe ES orders received in the third quarter of 2012 were for second systems from thought-leading hospitals in Europe. An early adopter of Stereotaxis technology in North America also ordered a second Niobe ES system in June 2012.
"The trend in second system sales is an indication of the value we are delivering through the Epoch™ platform, as well as the expanding utilization of our technology," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis. "With Niobe ES, we are enabling physicians to confidently perform complex procedures and treat difficult-to-reach areas of the heart, reigniting the excitement around robotics in the EP lab."
Kaminski says growing interest in the Company's latest generation robotic technology is translating into tangible results. "As anticipated, the continuation of upgrades in the installed base is leading to higher utilization, system orders and an increasing number of prospects interested in the proven value our platform offers."
The Company will provide details on third quarter results, including total Niobe ES system orders and upgrades, in November 2012.
Source: http://www.stereotaxis.com